SUBJECTS MEETING ALL THE INCLUSION CRITERIA AND NONE OF THE EXCLUSION CRITERIA DURING VISIT 1 (SCREENING VISIT) WILL ENTER A TWO WEEK RUN-IN PERIOD. SUBJECTS FAILING SCREENING WILL NOT BE ELIGIBLE FOR

A RANDOMIZED, DOUBLED-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FLUTICASONE FUROATE INHALATION POWDER AND FLUTICASONE PROPIONATE INHAATION POWDER IN THE TREATMENT OF ASTHMA IN ADULTS AND ADOLESCENTS NOT CURRENTLY TREATED WITH INHALED CORTICOSTEROIDS

FFA115283: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED (WHIT RESCUE MEDICATION), MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INHALED FLUTICASONE FUROATE IN THE TREATMENT OF PERSISTENT ASTHMA IN ADULTS AND ADOLESCENTS NOT CURRENTLY RECEIVING INHALED CORTICOSTEROIDS